SNV-derived neoantigens are novel epitopes from accumulated mutations within the cancer genome capable of expanding CD8+ T cell populations when presented on MHC class I. To understand the mutational burden in EO771 cells and the difference in mutational expression as cells undergo EMT, we performed variant calling from our RNAseq data. Here, CD8A is linked to cancer.